Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 389

1.

A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile-associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation.

Mullane KM, Winston DJ, Nooka A, Morris MI, Stiff P, Dugan MJ, Holland H, Gregg K, Adachi JA, Pergam SA, Alexander BD, Dubberke ER, Broyde N, Gorbach SL, Sears PS.

Clin Infect Dis. 2019 Jan 7;68(2):196-203. doi: 10.1093/cid/ciy484. Erratum in: Clin Infect Dis. 2019 Mar 19;68(7):1254.

2.

Passing the Mantle.

Gorbach SL.

Clin Infect Dis. 2016 Dec 15;63(12):1537-1538. No abstract available.

PMID:
27941142
3.

Rethinking Strategies to Select Antibiotic Therapy in Clostridium difficile infection.

Chopra T, Goldstein EJ, Gorbach SL.

Pharmacotherapy. 2016 Dec;36(12):1281-1289. doi: 10.1002/phar.1863. Review.

PMID:
27862113
4.

Fidaxomicin versus Vancomycin in the Treatment of Clostridium difficile Infection: Canadian Outcomes.

Lee C, Louie TJ, Weiss K, Valiquette L, Gerson M, Arnott W, Gorbach SL.

Can J Infect Dis Med Microbiol. 2016;2016:8048757. doi: 10.1155/2016/8048757. Epub 2016 May 24.

5.

Effects of proton pump inhibitors and histamine-2 receptor antagonists on response to fidaxomicin or vancomycin in patients with Clostridium difficile-associated diarrhoea.

Weiss K, Louie T, Miller MA, Mullane K, Crook DW, Gorbach SL.

BMJ Open Gastroenterol. 2015 Mar 2;2(1):e000028. doi: 10.1136/bmjgast-2014-000028. eCollection 2015.

6.

John G. Bartlett: Contributions to the discovery of Clostridium difficile antibiotic-associated diarrhea.

Gorbach SL.

Clin Infect Dis. 2014 Sep 15;59 Suppl 2:S66-70. doi: 10.1093/cid/ciu419.

PMID:
25151480
7.

Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America.

Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC; Infectious Diseases Society of America.

Clin Infect Dis. 2014 Jul 15;59(2):e10-52. doi: 10.1093/cid/ciu444. Erratum in: Clin Infect Dis. 2015 May 1;60(9):1448. Dosage error in article text.

PMID:
24973422
8.

Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America.

Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC.

Clin Infect Dis. 2014 Jul 15;59(2):147-59. doi: 10.1093/cid/ciu296. Epub 2014 Jun 18.

PMID:
24947530
9.

Whole-genome sequencing demonstrates that fidaxomicin is superior to vancomycin for preventing reinfection and relapse of infection with Clostridium difficile.

Eyre DW, Babakhani F, Griffiths D, Seddon J, Del Ojo Elias C, Gorbach SL, Peto TE, Crook DW, Walker AS.

J Infect Dis. 2014 May 1;209(9):1446-51. doi: 10.1093/infdis/jit598. Epub 2013 Nov 11.

10.

Reply to M.R. Green et al.

Cornely OA, Miller MA, Fantin BR, Mullane KM, Kean Y, Gorbach SL.

J Clin Oncol. 2013 Dec 1;31(34):4379. doi: 10.1200/JCO.2013.52.9420. Epub 2013 Oct 28. No abstract available.

PMID:
24166523
11.

Renal impairment and clinical outcomes of Clostridium difficile infection in two randomized trials.

Mullane KM, Cornely OA, Crook DW, Golan Y, Louie TJ, Miller MA, Josephson MA, Gorbach SL.

Am J Nephrol. 2013;38(1):1-11. doi: 10.1159/000351757. Epub 2013 Jun 20. Erratum in: Am J Nephrol. 2013;38(3):266.

PMID:
23796582
12.

Effect of age on treatment outcomes in Clostridium difficile infection.

Louie TJ, Miller MA, Crook DW, Lentnek A, Bernard L, High KP, Shue YK, Gorbach SL.

J Am Geriatr Soc. 2013 Feb;61(2):222-30. doi: 10.1111/jgs.12090. Epub 2013 Feb 4.

PMID:
23379974
13.

Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials.

Crook DW, Walker AS, Kean Y, Weiss K, Cornely OA, Miller MA, Esposito R, Louie TJ, Stoesser NE, Young BC, Angus BJ, Gorbach SL, Peto TE; Study 003/004 Teams.

Clin Infect Dis. 2012 Aug;55 Suppl 2:S93-103. doi: 10.1093/cid/cis499.

14.

Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin.

Cornely OA, Miller MA, Louie TJ, Crook DW, Gorbach SL.

Clin Infect Dis. 2012 Aug;55 Suppl 2:S154-61. doi: 10.1093/cid/cis462.

15.

Renal failure and leukocytosis are predictors of a complicated course of Clostridium difficile infection if measured on day of diagnosis.

Bauer MP, Hensgens MP, Miller MA, Gerding DN, Wilcox MH, Dale AP, Fawley WN, Kuijper EJ, Gorbach SL.

Clin Infect Dis. 2012 Aug;55 Suppl 2:S149-53. doi: 10.1093/cid/cis340.

16.

Sustained clinical response as an endpoint in treatment trials of Clostridium difficile-associated diarrhea.

Johnson S, Gerding DN, Louie TJ, Ruiz NM, Gorbach SL.

Antimicrob Agents Chemother. 2012 Aug;56(8):4043-5. doi: 10.1128/AAC.00605-12. Epub 2012 May 21. No abstract available.

17.

Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections.

Mullane KM, Miller MA, Weiss K, Lentnek A, Golan Y, Sears PS, Shue YK, Louie TJ, Gorbach SL.

Clin Infect Dis. 2011 Sep;53(5):440-7. doi: 10.1093/cid/cir404. Erratum in: Clin Infect Dis. 2011 Dec;53(12):1312. Dosage error in article text.

18.

Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006-2009.

Snydman DR, Jacobus NV, McDermott LA, Golan Y, Goldstein EJ, Harrell L, Jenkins S, Newton D, Pierson C, Rosenblatt J, Venezia R, Gorbach SL, Queenan AM, Hecht DW.

Anaerobe. 2011 Aug;17(4):147-51. doi: 10.1016/j.anaerobe.2011.05.014. Epub 2011 Jun 2.

PMID:
21664469
19.

Relationship between essential amino acids and muscle mass, independent of habitual diets, in pre- and post-menopausal US women.

Andrich DE, Filion ME, Woods M, Dwyer JT, Gorbach SL, Goldin BR, Adlercreutz H, Aubertin-Leheudre M.

Int J Food Sci Nutr. 2011 Nov;62(7):719-24. doi: 10.3109/09637486.2011.573772. Epub 2011 May 16.

PMID:
21568818
20.

Microbiology of the Gastrointestinal Tract.

Gorbach SL.

In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 95.

21.

Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007).

Snydman DR, Jacobus NV, McDermott LA, Golan Y, Hecht DW, Goldstein EJ, Harrell L, Jenkins S, Newton D, Pierson C, Rihs JD, Yu VL, Venezia R, Finegold SM, Rosenblatt JE, Gorbach SL.

Clin Infect Dis. 2010 Jan 1;50 Suppl 1:S26-33. doi: 10.1086/647940.

PMID:
20067390
22.

Estimated net acid excretion inversely correlates with urine pH in vegans, lacto-ovo vegetarians, and omnivores.

Ausman LM, Oliver LM, Goldin BR, Woods MN, Gorbach SL, Dwyer JT.

J Ren Nutr. 2008 Sep;18(5):456-65. doi: 10.1053/j.jrn.2008.04.007.

PMID:
18721741
23.

Changes in macronutrient intake among HIV-infected children between 1995 and 2004.

Sharma TS, Kinnamon DD, Duggan C, Weinberg GA, Furuta L, Bechard L, Nicchitta J, Gorbach SL, Miller TL.

Am J Clin Nutr. 2008 Aug;88(2):384-91.

24.

Probiotics for prevention of antibiotic-associated diarrhea.

Doron SI, Hibberd PL, Gorbach SL.

J Clin Gastroenterol. 2008 Jul;42 Suppl 2:S58-63. doi: 10.1097/MCG.0b013e3181618ab7. Review.

PMID:
18542041
25.

Risk factors for cardiovascular disease in children infected with human immunodeficiency virus-1.

Miller TL, Orav EJ, Lipshultz SE, Arheart KL, Duggan C, Weinberg GA, Bechard L, Furuta L, Nicchitta J, Gorbach SL, Shevitz A.

J Pediatr. 2008 Oct;153(4):491-7. doi: 10.1016/j.jpeds.2008.04.016. Epub 2008 Jun 9.

26.

Cystatin C and creatinine in an HIV cohort: the nutrition for healthy living study.

Jones CY, Jones CA, Wilson IB, Knox TA, Levey AS, Spiegelman D, Gorbach SL, Van Lente F, Stevens LA.

Am J Kidney Dis. 2008 Jun;51(6):914-24. doi: 10.1053/j.ajkd.2008.01.027. Epub 2008 May 2.

27.

Safety, tolerance, and pharmacokinetic studies of OPT-80 in healthy volunteers following single and multiple oral doses.

Shue YK, Sears PS, Shangle S, Walsh RB, Lee C, Gorbach SL, Okumu F, Preston RA.

Antimicrob Agents Chemother. 2008 Apr;52(4):1391-5. doi: 10.1128/AAC.01045-07. Epub 2008 Feb 11.

28.

Drug use and other risk factors related to lower body mass index among HIV-infected individuals.

Quach LA, Wanke CA, Schmid CH, Gorbach SL, Mwamburi DM, Mayer KH, Spiegelman D, Tang AM.

Drug Alcohol Depend. 2008 May 1;95(1-2):30-6. doi: 10.1016/j.drugalcdep.2007.12.004. Epub 2008 Feb 19.

29.

Clinical indications for probiotics: an overview.

Goldin BR, Gorbach SL.

Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S96-100; discussion S144-51. doi: 10.1086/523333. Review.

PMID:
18181732
30.

Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV.

Mangili A, Jacobson DL, Gerrior J, Polak JF, Gorbach SL, Wanke CA.

Clin Infect Dis. 2007 May 15;44(10):1368-74. Epub 2007 Apr 5.

31.

National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004.

Snydman DR, Jacobus NV, McDermott LA, Ruthazer R, Golan Y, Goldstein EJ, Finegold SM, Harrell LJ, Hecht DW, Jenkins SG, Pierson C, Venezia R, Yu V, Rihs J, Gorbach SL.

Antimicrob Agents Chemother. 2007 May;51(5):1649-55. Epub 2007 Feb 5.

32.

Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score.

Mangili A, Gerrior J, Tang AM, O'Leary DH, Polak JK, Schaefer EJ, Gorbach SL, Wanke CA.

Clin Infect Dis. 2006 Dec 1;43(11):1482-9. Epub 2006 Oct 31.

PMID:
17083026
33.

Incidence of metabolic syndrome in a cohort of HIV-infected adults and prevalence relative to the US population (National Health and Nutrition Examination Survey).

Jacobson DL, Tang AM, Spiegelman D, Thomas AM, Skinner S, Gorbach SL, Wanke C.

J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):458-66.

PMID:
16980905
34.

Update on Clostridium difficile.

Thorpe CM, Gorbach SL.

Curr Treat Options Gastroenterol. 2006 Jun;9(3):265-71.

PMID:
16901390
35.

Probiotics: their role in the treatment and prevention of disease.

Doron S, Gorbach SL.

Expert Rev Anti Infect Ther. 2006 Apr;4(2):261-75. Review.

PMID:
16597207
36.

Practice guidelines for the diagnosis and management of skin and soft-tissue infections.

Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan EL, Montoya JG, Wade JC; Infectious Diseases Society of America.

Clin Infect Dis. 2005 Nov 15;41(10):1373-406. Epub 2005 Oct 14. No abstract available. Erratum in: Clin Infect Dis. 2005 Dec 15;41(12):1830. Clin Infect Dis. 2006 Apr 15;42(8):1219. Dosage error in article text.

PMID:
16231249
37.

Insulin resistance in HIV-infected men and women in the nutrition for healthy living cohort.

Jones CY, Wilson IB, Greenberg AS, Shevitz A, Knox TA, Gorbach SL, Spiegelman D, Jacobson DL, Wanke C.

J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):202-11.

PMID:
16186739
38.

Predictors of bone mineral density in human immunodeficiency virus-1 infected children.

Jacobson DL, Spiegelman D, Duggan C, Weinberg GA, Bechard L, Furuta L, Nicchitta J, Gorbach SL, Miller TL.

J Pediatr Gastroenterol Nutr. 2005 Sep;41(3):339-46.

PMID:
16131991
39.

Lactobacillus GG: bacteriology and clinical applications.

Doron S, Snydman DR, Gorbach SL.

Gastroenterol Clin North Am. 2005 Sep;34(3):483-98, ix. Review. No abstract available.

PMID:
16084309
40.

Predicting CD4 count using total lymphocyte count: a sustainable tool for clinical decisions during HAART use.

Mwamburi DM, Ghosh M, Fauntleroy J, Gorbach SL, Wanke CA.

Am J Trop Med Hyg. 2005 Jul;73(1):58-62.

PMID:
16014833
41.

The effect of micronutrient supplementation on disease progression and death in simian immunodeficiency virus-infected juvenile male rhesus macaques.

Goldin BR, Li W, Mansfield K, Woods M, Wanke C, Freeman L, Shevitz A, Gualtieri L, Bussell S, Gorbach SL.

J Infect Dis. 2005 Jul 15;192(2):311-8. Epub 2005 Jun 14.

PMID:
15962226
42.

Protease inhibitor-based HAART, HDL, and CHD-risk in HIV-infected patients.

Asztalos BF, Schaefer EJ, Horvath KV, Cox CE, Skinner S, Gerrior J, Gorbach SL, Wanke C.

Atherosclerosis. 2006 Jan;184(1):72-7. Epub 2005 Jun 1.

PMID:
15935358
43.

How to hit the runs for fifty million travelers at risk.

Gorbach SL.

Ann Intern Med. 2005 May 17;142(10):861-2. No abstract available.

PMID:
15897537
44.

Differences in serum sex hormone and plasma lipid levels in Caucasian and African-American premenopausal women.

Lamon-Fava S, Barnett JB, Woods MN, McCormack C, McNamara JR, Schaefer EJ, Longcope C, Rosner B, Gorbach SL.

J Clin Endocrinol Metab. 2005 Aug;90(8):4516-20. Epub 2005 May 10.

PMID:
15886254
45.

A word on nutrition and HIV/AIDS.

Gorbach SL.

Nutr Clin Care. 2005 Jan-Mar;8(1):1. No abstract available.

PMID:
15850227
46.

A comparison of the clinical and cost-effectiveness of 3 intervention strategies for AIDS wasting.

Shevitz AH, Wilson IB, McDermott AY, Spiegelman D, Skinner SC, Antonsson K, Layne JE, Beaston-Blaakman A, Shepard DS, Gorbach SL.

J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):399-406.

PMID:
15764956
47.

The effect of drug abuse on body mass index in Hispanics with and without HIV infection.

Forrester JE, Tucker KL, Gorbach SL.

Public Health Nutr. 2005 Feb;8(1):61-8.

PMID:
15705246
48.

Understanding the role of HIV load in determining weight change in the era of highly active antiretroviral therapy.

Mwamburi DM, Wilson IB, Jacobson DL, Spiegelman D, Gorbach SL, Knox TA, Wanke CA.

Clin Infect Dis. 2005 Jan 1;40(1):167-73. Epub 2004 Dec 8.

PMID:
15614708
49.

Dietary intake and body mass index in HIV-positive and HIV-negative drug abusers of Hispanic ethnicity.

Forrester JE, Tucker KL, Gorbach SL.

Public Health Nutr. 2004 Oct;7(7):863-70.

PMID:
15482611
50.

Body-composition changes in the simian immunodeficiency virus-infected juvenile rhesus macaque.

Freeman LM, Mansfield KG, Goldin B, Woods M, Gualtieri L, Li W, Bussell S, Lackner A, Gorbach SL.

J Infect Dis. 2004 Jun 1;189(11):2010-5. Epub 2004 May 11.

PMID:
15143467

Supplemental Content

Loading ...
Support Center